Results 31 to 40 of about 70,208 (264)

LUJO HEMORRHAGIC FEVER

open access: yesProblems of Virology, 2017
Lujo hemorrhagic fever (LHF) is a viral disease accompanied with fever, headache, vomiting, diarrhea, arthralgia, myalgia and numerous signs of hemorrhagic syndrome. LHF causes a clinical syndrome remarkably similar to Lassa hemorrhagic fever. The first case of LHF occurred in Johannesburg, South Africa, in 2008. There was a secondary transmission from
T. E. Sizikova   +3 more
openaire   +3 more sources

Reconstruction of the Evolutionary History and Dispersal of Usutu Virus, a Neglected Emerging Arbovirus in Europe and Africa

open access: yesmBio, 2016
Usutu virus (USUV), one of the most neglected Old World encephalitic flaviviruses, causes epizootics among wild and captive birds and sporadic infection in humans. The dynamics of USUV spread and evolution in its natural hosts are unknown.
Dimitri Engel   +14 more
doaj   +1 more source

Human Usutu Virus Infections in Europe: A New Risk on Horizon?

open access: yesViruses, 2022
The Usutu virus (USUV), a neurotropic mosquito-borne flavivirus discovered in 1959 in South Africa, has spread over the last twenty years across the European continent. This virus follows an enzootic cycle involving mosquitoes and birds.
Dániel Cadar, Yannick Simonin
doaj   +1 more source

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

open access: yesNature Communications, 2016
Lassa virus can cause haemorrhagic fever for which no specific treatment currently exists. Here the authors have cloned 113 monoclonal antibodies from the survivors of Lassa infection and show that the majority of neutralizing antibodies target a complex
James E. Robinson   +49 more
doaj   +1 more source

Larval sites of the mosquito Aedes aegypti formosus in forest and domestic habitats in Africa and the potential association with oviposition evolution

open access: yesEcology and Evolution, 2021
Adaptations to anthropogenic domestic habitats contribute to the success of the mosquito Aedes aegypti as a major global vector of several arboviral diseases.
Siyang Xia   +7 more
doaj   +1 more source

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations

open access: yesBMC Pharmacology and Toxicology, 2022
Background COVID-19 pandemic has claimed millions of lives and devastated the health service system, livelihood, and economy in many countries worldwide.
Kunlakanya Jitobaom   +7 more
doaj   +1 more source

Risk factors associated with sustained circulation of six zoonotic arboviruses: a systematic review for selection of surveillance sites in non-endemic areas

open access: yesParasites & Vectors, 2019
Arboviruses represent a significant burden to public health and local economies due to their ability to cause unpredictable and widespread epidemics. To maximize early detection of arbovirus emergence in non-endemic areas, surveillance efforts should ...
Helen J. Esser   +8 more
doaj   +1 more source

Investigation of the Relationship Between TAFI Plasma Levels and Hemorrhage in Patients with Crimean-Congo Hemorrhagic Fever and the Role of TAFI in the Disease Pathogenesis

open access: yesCerrahpaşa Medical Journal, 2021
Objective: Crimean-Congo hemorrhagic fever is a tick-borne viral infection presenting with fever and bleeding. Thrombin-activatable fibrinolysis inhibitor is a plasma procarboxypeptidase synthesized in the liver, causing downregulation of fibrinolysis ...
Hüsna Şengül Aşkın   +5 more
doaj   +1 more source

Dengue and Dengue Hemorrhagic Fever [PDF]

open access: yesClinical Microbiology Reviews, 1997
SUMMARYDengue fever, a very old disease, has reemerged in the past 20 years with an expanded geographic distribution of both the viruses and the mosquito vectors, increased epidemic activity, the development of hyperendemicity (the cocirculation of multiple serotypes), and the emergence of dengue hemorrhagic fever in new geographic regions.
openaire   +3 more sources

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy